Market Overview:
The global swine flu vaccine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of swine flu, rising awareness about swine flu vaccines, and technological advancements in the field of vaccine production. The global swine flu vaccine market is segmented on the basis of type, application, and region. On the basis of type, it is divided into intradermal vaccination, intramuscular vaccination, subcutaneous vaccination, and others. Intradermal vaccines are administered through a small needle that injects the vaccine just below the skin’s surface. Intramuscular vaccines are injected into muscle tissue using a larger needle than for intradermal injections. Subcutaneous injections involve injecting a drug or vaccine just under your skin with a syringe or autoinjector device like an EpiPen® .On the basis of application, it is segmented into hospital pharmacies , retail pharmacies , online pharmacies , clinic and vaccination centers .
Product Definition:
A vaccine is a preparation of killed or attenuated organisms, or purified products derived from them, used to induce immunity in humans or animals. The swine flu vaccine protects people against the H1N1 virus. It is made from killed viruses that have been grown in eggs.
Intradermal Vaccination:
Intradermal vaccination is a method of vaccine administration in which the vaccine is placed in the epidermis (outermost skin layer) by using a needle, jet injector or cream dispenser. The advantages of intradermal vaccination include minimal pain and discomfort, quick response, and effective immunization.
Intramuscular Vaccination:
Intramuscular vaccination is a procedure wherein vaccine is injected into muscle tissues of the body. The most commonly used muscles are deltoid, gastrocnemius and quadriceps. Intramuscular route allows rapid absorption of the vaccine compared to other routes of administration such as oral or intranasal.
Application Insights:
Based on application, the global market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and clinic and vaccination centers. The hospital pharmacy segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as presence of a large patient base that visits hospitals for diagnosis or treatment purposes coupled with high demand for vaccines from this sector.
The retail pharmacy segment is expected to witness lucrative growth over the forecast period owing to growing awareness among consumers regarding access to affordable drugs through these stores which offer savings of up to 80% compared to regular drug stores due largelyto their larger inventory holding capacity. Moreover, increasing number of chain retail stores across various regions further boosts product penetration at lower prices than what is charged by traditional outlets such as hospitals and clinics which are considered major driving forces behind projected growth rate over next seven years.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of swine producers coupled with high spending power and awareness about vaccination programs are some factors contributing to the growth of this regional market. Furthermore, increasing efforts by government organizations to create awareness regarding H1N1 vaccination is expected to drive demand for these vaccines over the forecast period.
Asia Pacific is anticipated to witness significant growth during the forecast period owing to rising investments by governments in developing countries such as China and India for improving healthcare infrastructure and raising public health expenditure. In addition, growing population along with increased travel & trade activities are likely boost demand for influenza vaccines in this region over the next eight years.
Growth Factors:
- Increasing awareness about the benefits of vaccination against swine flu
- Growing number of people travelling to and from countries where the virus is prevalent
- Rapid increase in the number of cases being reported globally
- Stringent government regulations for vaccinating personnel working in high-risk areas
- Rising demand for preventive measures against pandemics
Scope Of The Report
Report Attributes
Report Details
Report Title
Swine Flu Vaccine Market Research Report
By Type
Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinic And Vaccination Centers
By Companies
Novartis, CSL Limited, Zydus Cadila, AstraZeneca, GlaxoSmithKline, Sanofi, Baxter, Sinovac Biotech, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
167
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Swine Flu Vaccine Market Report Segments:
The global Swine Flu Vaccine market is segmented on the basis of:
Types
Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinic And Vaccination Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- CSL Limited
- Zydus Cadila
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Baxter
- Sinovac Biotech
- Novartis
Highlights of The Swine Flu Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intradermal Vaccination
- Intramuscular Vaccination
- Subcutaneous Vaccination
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Clinic And Vaccination Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Swine Flu Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The swine flu vaccine is a vaccine that helps protect people from the swine flu. It is made up of pieces of the virus, and it helps your body learn how to fight off the virus if you get sick with it. The vaccine can help prevent you from getting sick with the swine flu, and it can also help reduce your risk of getting serious health problems if you do get sick with the virus.
Some of the major players in the swine flu vaccine market are Novartis, CSL Limited, Zydus Cadila, AstraZeneca, GlaxoSmithKline, Sanofi, Baxter, Sinovac Biotech, Novartis.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Swine Flu Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Swine Flu Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Swine Flu Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Swine Flu Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Swine Flu Vaccine Market Size & Forecast, 2018-2028
4.5.1 Swine Flu Vaccine Market Size and Y-o-Y Growth
4.5.2 Swine Flu Vaccine Market Absolute $ Opportunity
Chapter 5 Global Swine Flu Vaccine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Swine Flu Vaccine Market Size Forecast by Type
5.2.1 Intradermal Vaccination
5.2.2 Intramuscular Vaccination
5.2.3 Subcutaneous Vaccination
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Swine Flu Vaccine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Swine Flu Vaccine Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.2.4 Clinic And Vaccination Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Swine Flu Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Swine Flu Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Swine Flu Vaccine Analysis and Forecast
9.1 Introduction
9.2 North America Swine Flu Vaccine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Swine Flu Vaccine Market Size Forecast by Type
9.6.1 Intradermal Vaccination
9.6.2 Intramuscular Vaccination
9.6.3 Subcutaneous Vaccination
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Swine Flu Vaccine Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.10.4 Clinic And Vaccination Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Swine Flu Vaccine Analysis and Forecast
10.1 Introduction
10.2 Europe Swine Flu Vaccine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Swine Flu Vaccine Market Size Forecast by Type
10.6.1 Intradermal Vaccination
10.6.2 Intramuscular Vaccination
10.6.3 Subcutaneous Vaccination
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Swine Flu Vaccine Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.10.4 Clinic And Vaccination Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Swine Flu Vaccine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Swine Flu Vaccine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Swine Flu Vaccine Market Size Forecast by Type
11.6.1 Intradermal Vaccination
11.6.2 Intramuscular Vaccination
11.6.3 Subcutaneous Vaccination
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Swine Flu Vaccine Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.10.4 Clinic And Vaccination Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Swine Flu Vaccine Analysis and Forecast
12.1 Introduction
12.2 Latin America Swine Flu Vaccine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Swine Flu Vaccine Market Size Forecast by Type
12.6.1 Intradermal Vaccination
12.6.2 Intramuscular Vaccination
12.6.3 Subcutaneous Vaccination
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Swine Flu Vaccine Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.10.4 Clinic And Vaccination Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Swine Flu Vaccine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Swine Flu Vaccine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Swine Flu Vaccine Market Size Forecast by Type
13.6.1 Intradermal Vaccination
13.6.2 Intramuscular Vaccination
13.6.3 Subcutaneous Vaccination
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Swine Flu Vaccine Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.10.4 Clinic And Vaccination Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Swine Flu Vaccine Market: Competitive Dashboard
14.2 Global Swine Flu Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 CSL Limited
14.3.3 Zydus Cadila
14.3.4 AstraZeneca
14.3.5 GlaxoSmithKline
14.3.6 Sanofi
14.3.7 Baxter
14.3.8 Sinovac Biotech
14.3.9 Novartis
